David S Liebeskind
David S Liebeskind, MD, MBA is an expert in Neurology at University of California, Los Angeles (United States). As of October 2026, ScienceLeadR ranks David S Liebeskind in the top 1% of experts worldwide for Cerebrovascular Disorders, Brain Ischemia and Brain Infarction. David S Liebeskind has authored 1,592 publications, the most recent in 2026, and is an investigator in 74 clinical trials, 5 of them ongoing. SLR score: 6,029 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Cardiology - Medical Imaging - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 1592
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Cerebral No-Reflow after Thrombectomy: International Delphi Consensus on Definition and Imaging Assessment. PMID 42861924 — reperfusion, thrombectomy | Ann Neurol | 2026 | 0 |
| Neuropsychiatric Symptom Associations with NOTCH3 Genotype in the United States CADASIL Consortium. PMID 42856679 — cadasil, signs and symptoms, genotype | medRxiv | 2026 | 0 |
| Adjuvant Systemic Hypothermia During Mechanical Thrombectomy (ReCCLAIM II): A Multicenter, Randomized, Controlled Trial. PMID 42852505 — ischemic stroke, stroke, arteries, drug-related side effects and adverse reactions, cerebrovascular circulation, reperfusion, hypothermia, cerebrovascular disorders, therapeutics, punctures, cerebral infarction, thrombectomy, temperature | Stroke | 2026 | 0 |
| Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR. PMID 42839308 — stroke, neoplasms, therapeutics, history, nervous system diseases, embolic stroke, forests, embolic stroke of undetermined source | Ann Clin Transl Neurol | 2026 | 0 |
| The United States CADASIL Consortium: Baseline Findings from a Natural History Study. PMID 42818124 — dementia, natural history, genetics, cadasil, biomarkers, history, education | medRxiv | 2026 | 0 |
Clinical Studies 74
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence NCT06398366 — ischemic stroke, stroke, heart failure, heart, multiple chronic conditions, cohort studies, atherosclerosis, embolic stroke, cardiomyopathies | N/A | Enrolling by invitation | 2022 |
| International Post Stroke Epilepsy Research Repository NCT06108102 — epilepsy, stroke, neuroimaging, hemorrhagic stroke, seizures, diagnosis, research, prognosis | N/A | Enrolling by invitation | 2024 |
| Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study NCT05677880 — dementia, blood, cognitive dysfunction, cadasil, dementia, vascular, leukoencephalopathies, cognition disorders, nerve degeneration, self report | N/A | Recruiting | 2022 |
| Intra arterial Recombinant Human TNK Tissue type Plasminogen Activator (rhTNK tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization NCT05624190 — ischemic stroke, stroke, plasminogen, plasminogen activators, tissue plasminogen activator, tenecteplase, tissues, thrombectomy | Phase 4 | Recruiting | 2023 |
| Platelet Expression of Fc RIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis NCT05518305 — ischemic stroke, stroke, magnetic resonance imaging, diagnostic imaging, atherosclerosis, blood platelets, ischemia, hemodynamics | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map